GlassScriptPhysician profile
Farah Alani
NPI 1821331729
$3,287.56
in general payments reported to CMS, 2019-2025
17 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $459 · 2021: $820 · 2022: $1,051 · 2023: $460 · 2024: $14.24 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $955.67 | 2021-2025 | Ortholoc 3di |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $597.45 | 2020-2022 | |
| Horizon Therapeutics Plc | $529.50 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $165.70 | 2020-2024 | Jublia |
| Djo, LLC | $156.97 | 2023-2025 | Cmf |
| Alafair Biosciences, INC. | $150.00 | 2023 | Versawrap |
| Axsome Therapeutics, INC. | $149.53 | 2023 | Auvelity |
| Boston Scientific Corporation | $134.46 | 2021-2023 | |
| Medtronic, INC. | $126.09 | 2021 | |
| Novo Nordisk INC | $115.37 | 2020 | |
| Zimmer Biomet Holdings, INC. | $48.86 | 2021 | |
| Almatica Pharma LLC | $46.07 | 2021 | |
| Sebela Pharmaceuticals INC. | $38.79 | 2020-2021 | |
| Royal Biologics, INC. | $35.63 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.73 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $14.61 | 2021 | |
| Orthofix Medical, INC. | $5.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farah Alani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.